What is the ARCH.V share price today?

This page shows the latest available Arch Biopartners Inc. (ARCH.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is Arch Biopartners Inc. listed?

Arch Biopartners Inc. trades on the TSX Venture Exchange under the symbol ARCH.V, ISIN CA03938C1041.

How large is Arch Biopartners Inc.?

Its market capitalisation is approximately 62.5M CAD, based on the latest available price and share count from our data provider.

TSX Venture Exchange (TSXV) · ARCH.V · ISIN CA03938C1041

Arch Biopartners Inc.

0.8600 CAD

−0.06(−6.52%)

Previous close · Sep 18, 15:59 ET

Data last updated: Sep 18, 15:59 ET (21 h ago)· Delayed exchange data

Arch Biopartners Inc. (ARCH.V) trades on the TSX Venture Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 62.5M CAD. The company reports around 6 employees. Its ISIN is CA03938C1041. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

TSX Venture Exchange (TSXV)

ISIN

CA03938C1041

Sector

Healthcare

Industry

Biotechnology

Country

Market cap

58.42M CAD

Employees

Previous close

0.92 CAD

Day range

0.84 – 0.93

52-week range

0.39 – 1.66

Volume

53.24K

50-day average

0.96 CAD

200-day average

0.85 CAD

Asset type

Equity

About Arch Biopartners Inc.

Arch Biopartners Inc. is a biotechnology firm dedicated to devising groundbreaking solutions for both medical and commercial applications. A significant focus for the company is the advancement of Metablok, a key therapeutic agent designed to address or avert dipeptidase-1 driven inflammation in critical organs such as the lungs, liver, and kidneys. This inflammatory response can lead to profound organ dysfunction or complete failure, particularly in conditions like sepsis and COVID-19. Moreover, Arch Biopartners is developing AB569, an experimental medication intended to combat antibiotic-resistant bacterial infections, primarily through topical application on wounds. Their innovative product pipeline also features Borg, a specialized peptide-solid surface interface developed to hinder biofilm formation and lessen material corrosion. Lastly, MetaMx involves synthetic compounds engineered to target the cells that initiate brain tumors and invasive glioma cells. The company's operations are based out of Toronto, Canada.

Company website

Frequently asked

What is the ARCH.V share price today?: This page shows the latest available Arch Biopartners Inc. (ARCH.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is Arch Biopartners Inc. listed?: Arch Biopartners Inc. trades on the TSX Venture Exchange under the symbol ARCH.V, ISIN CA03938C1041.
How large is Arch Biopartners Inc.?: Its market capitalisation is approximately 62.5M CAD, based on the latest available price and share count from our data provider.

All Arch Biopartners Inc. data comes from exchange and provider feeds for the TSX Venture Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.